Reconstructing targetable pathways in lung cancer by integrating diverse omics data
about
Update in Lung Cancer 2014Integrating Epigenomics into the Understanding of Biomedical InsightFrom Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical ResearchNovel Application of Junction Trees to the Interpretation of Epigenetic Differences among Lung Cancer SubtypesDecoding Cellular Dynamics in Epidermal Growth Factor Signaling Using a New Pathway-Based Integration Approach for Proteomics and Transcriptomics Data.Integrative analysis of human omics data using biomolecular networks.Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerIntegrating phosphoproteomics in systems biology.Integrative analysis of multiple diverse omics datasets by sparse group multitask regression.Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.KRAS and the Reality of Personalized Medicine in Non-small Cell Lung Cancer.LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies.Adaptive protein and phosphoprotein networks which promote therapeutic sensitivity or acquired resistance.Proteomics for systems toxicology.Modeling K-Ras-driven lung adenocarcinoma in mice: preclinical validation of therapeutic targets.Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.Targeting PAK1.Flux control through protein phosphorylation in yeast.Upregulation of mediator MED23 in non-small-cell lung cancer promotes the growth, migration, and metastasis of cancer cells.C-reactive protein upregulates the whole blood expression of CD59 - an integrative analysis.Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase.KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target.The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold.Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers.
P2860
Q4649475-06DF7879-D44D-4479-BD78-B076C2F4A7EDQ54907773-469B6CA1-659B-48D2-B260-A342FC0217DEQ54907854-CB9F50E3-CFD5-4ECB-9919-22EC0D2597C1Q54907864-43550150-2A53-4B11-B961-F9FEF8F2A99BQ54907901-5036530A-5FB2-4BA7-B228-A9FB34F61B44Q54907928-D1B64AEE-BD51-4403-AB4D-EF6A42AC4AACQ54907958-725EB96A-4CBB-4A7C-9A64-41B233D43200Q54908041-86939199-EDB2-4772-8837-909EAF02C289Q54908052-1E20FDAB-7675-46A5-B2BB-8C04A9A3056EQ54908057-B9C1760C-48B7-4200-9A77-23F99065142DQ54908114-68882753-67B8-4DC7-81CC-5089A4F0ADD2Q54953746-499DEF29-2BC8-40D9-B127-A253D22BF0A2Q54971217-21604ADA-61AA-47A5-AB72-BE37E7114E1D
P1343
Q27027385-92EEB4A0-279A-4580-9B39-318D166BE1BAQ28077579-56A04DA6-F60A-4C15-A32B-47EFA92EAB5FQ28393309-84D64DDA-F9CB-4B84-BB36-8C2E0780420EQ28645621-97DB8135-84A3-4147-9735-F8E66095B623Q31037462-B53AFEAB-1DEB-4B46-B65B-57BDF648FA09Q31120979-2082A981-BEEB-4B1A-AECD-0F1300BA2F71Q34295621-5315F8BC-A59F-419A-BA59-2A68D60C286EQ34377093-74FD7A4B-EF67-4634-8D4A-A696E44E0FD5Q34406579-CDF89B7E-B138-40CC-AD47-ED00E81AA38BQ35808124-92B90769-98E8-4966-B6E2-CB0EC4867098Q36154689-1B570C1B-1519-4D12-9713-5F324B2F4AB7Q37353957-ECE9882B-E6B6-4615-B3CF-15E30E09BA9BQ37716567-370CA4B8-1AF5-46CE-853B-D35418594315Q38238602-65FB828D-C069-437C-ABA4-1613A76B52A3Q38266035-DB88EDD4-E514-4061-8C2A-697F7924852AQ38622790-312F1993-F63F-4E52-92AC-E3D74000CA6DQ38740566-36F75FC3-FC62-4DA1-8D38-4753D3ED23C8Q38757029-EBD86332-BD12-4026-99E0-C717CFD37E1CQ38802024-83496A37-461C-431C-8024-F6CD2FF22FA2Q38951560-ED6E2F93-A68F-4B92-BB13-963EF58A566CQ41935388-6EB607BC-3D77-4018-ACD3-42738307226DQ47547494-C99374E9-7B92-40FB-9A63-70E6A0625631Q49887897-8D38C463-8D72-44C0-B9D1-699CD783CA41Q50130103-17BFA845-CF7D-4342-A3AB-46C976A92D31Q55442248-3320C6B7-2C82-46DC-B39F-BE6AC6C04D63
P2860
Reconstructing targetable pathways in lung cancer by integrating diverse omics data
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Reconstructing targetable pathways in lung cancer by integrating diverse omics data
@ast
Reconstructing targetable pathways in lung cancer by integrating diverse omics data
@en
type
label
Reconstructing targetable pathways in lung cancer by integrating diverse omics data
@ast
Reconstructing targetable pathways in lung cancer by integrating diverse omics data
@en
prefLabel
Reconstructing targetable pathways in lung cancer by integrating diverse omics data
@ast
Reconstructing targetable pathways in lung cancer by integrating diverse omics data
@en
P2093
P2860
P4510
P50
P356
P1476
Reconstructing targetable pathways in lung cancer by integrating diverse omics data
@en
P2093
Anastasia Yocum
Anirban Sahu
Arul M Chinnaiyan
Benjamin Chandler
Dafydd Thomas
Damian Fermin
David G Beer
O Alejandro Balbin
Rohit Malik
Sunita Shankar
P2860
P2888
P356
10.1038/NCOMMS3617
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1045535054